Author: Dr. Savatta
-
Robotic prostatectomy findings in patients with a single microfocus (5% or Less) of Gleason 6 Prostate Cancer at Biopsy
A Single Microfocus (5% or Less) of Gleason 6 Prostate Cancer at Biopsy-Can We Predict Adverse Pathological Outcomes? Source: Urotoday While a microfocus of Gleason score 6 prostate cancer on biopsy is commonly considered low risk disease, there was a greater than 1/5 risk of pathological upgrading and/or up staging. Patients with Gleason score 6…
-
MedWire News – Prostate Cancer – Endocrine and radiotherapy ‘standard care’ for locally advanced prostate cancer
Source Medwire News Adding local radiotherapy to endocrine treatment halves the 10-year prostate cancer-specific mortality in patients with locally advanced or high-risk local prostate cancer compared with endocrine treatment alone, researchers report. “In the light of these data, endocrine treatment plus radiotherapy should be the new standard,” Anders Widmark (Umeå University, Sweden) and team write…
-
Dr Moyad on Vitamin E- Do not take over 400 IU daily
Source: Dr. Moyad on December 2008 Newsletter “It is now 100% official, high-doses (400 IU or more per day) of vitamin E supplements should not be taken by anyone, especially men trying to prevent, those diagnosed, or even treated for prostate cancer (in other words all men on planet earth)!!!” Dr. Moyad is in my opinion, the most…
-
Impact of Accessory Pudendal Arteries on Potency Following Robot-Assisted Prostatectomy
Source: UroToday from 2008 Wold Congress of Endourology After multivariate analysis there was no significance with sacrificing an APA and time of potency recovery. There was no correlation with sacrificing an APA and postoperative quality of erections (94% vs 90% p=0.30) or mean IIEF-5 (22.4 vs 20.7 p=0.11). As one of the few reports regarding…
-
Robotic Inguinal Hernia Surgery at the time of Robotic Prostatectomy
Source: Journal of Robotic Surgery, Volume 1, Number 4 / February, 2008 Conclusion Urological surgeons should be encouraged to perform a thorough inguinal exam during preoperative evaluation and intraoperatively to detect subclinical hernias. Inguinal herniorrhaphy done concurrently at the time of RALP is safe, with no added morbidity and should be routinely performed. This is…
-
Robotic Partial Nephrectomy Study
Source: Journal of Robotic Surgery, Volume 2, Number 3 / September, 2008 Conclusions We report a large, multi-institutional series of RPN for renal tumors, confirming safety and feasibility reported in previous small, single-institution studies. Although we report the initial experience in RPN at each center, immediate oncologic results and perioperative outcomes approached those of more…
-
Risk of prostate cancer unaffected by antibiotic treatment
Source: MedWire News The average age of the patients was 62.9 years. Average total PSA before and after treatment was 6.05 ng/ml and 5.55 ng/ml, respectively. On biopsy, 23% of patients had histologically proven prostate cancer. There were no significant differences between men with and without prostate cancer in age, pretreatment PSA, free PSA, percent…
-
Robotic Partial Nephrectomy Versus Laparoscopic Partial Nephrectomy for Renal Cell Carcinoma: Single-Surgeon Analysis of >100 Consecutive Procedures
Source: UroToday The mean total operative time (140 vs 156 minutes, P = .04), warm ischemia time (19 vs 25 minutes, P = .03), and length of stay (2.5 vs 2.9 days, P = .03) were significantly shorter for RPN than for LPN, respectively. RPN can produce results comparable to LPN but has disadvantages, such…
-
SELECT: Selenium, vitamin E show no benefit in prostate cancer prevention – – UrologyTimes
Source: Urology Times Selenium and vitamin E supplements, taken either alone or together, do not appear to prevent prostate cancer, according to an initial, independent review of study data from the Selenium and Vitamin E Cancer Prevention Trial (SELECT). The data also showed two concerning trends: a small but not statistically significant increase in the…